The short version
Only one company currently supplies this market — there is no backup if it stumbles. The price is up 22% over the past year, to $40.13 per mL.
Market view
dihydroergotamine mesylate nasal
2 marketed package NDCs · 1 active manufacturer
Most dispensed: DIHYDROERGOTAMINE MESYLATE 4 mg/mL · Spray, Metered · #1 vial/kit / 1 ml in 1 vial · DIHYDROERGOTAMINE MESYLATE 4 mg/mL · Spray, Metered · #8 vials/kit / 1 ml in 1 vial
Price range and competition
RSS: changes for this drugEvery company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.
Latest · Sep 2026 — typical price $40.13 · middle half $35.14–$45.12 · full range $30.15–$50.12 · 2 products · 1 companies
ⓘ How this was built
Data sources
- CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
- CMS Federal Upper Limit files (weighted AMP)
- FDA NDC Directory (openFDA) — maker roster
Method
Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
What changed in the last 90 days
Every detected change for dihydroergotamine mesylate nasal, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Dihydroergotamine Mesylate NasalAug 19, 2026Price downNADAC $31.51813 → $30.14777 per unit (-4.35%)
- Dihydroergotamine Mesylate NasalJul 22, 2026Price downNADAC $33.72544 → $31.51813 per unit (-6.54%)
Same drug class
Other molecules FDA puts in Ergotamine Derivative, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Dihydroergotamine mesylate nasal in shortage right now?
- No. FDA does not currently list Dihydroergotamine mesylate nasal in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Dihydroergotamine mesylate nasal?
- 1 company has marketed Dihydroergotamine mesylate nasal in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
- What does Dihydroergotamine mesylate nasal cost?
- The typical pharmacy pays about $40.13 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.